Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Humanized mice: novel model for studying mechanisms of human immune-based therapies.

Gonzalez L, Strbo N, Podack ER.

Immunol Res. 2013 Dec;57(1-3):326-34. doi: 10.1007/s12026-013-8471-2. Review.

2.

Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Zhang L, Meissner E, Chen J, Su L.

Sci China Life Sci. 2010 Feb;53(2):195-203. doi: 10.1007/s11427-010-0059-7. Epub 2010 Mar 7. Review.

3.

Humanized mice for human retrovirus infection.

Koyanagi Y, Tanaka Y, Ito M, Yamamoto N.

Curr Top Microbiol Immunol. 2008;324:133-48. Review.

PMID:
18481458
4.

HIV-1 immunopathogenesis in humanized mouse models.

Zhang L, Su L.

Cell Mol Immunol. 2012 May;9(3):237-44. doi: 10.1038/cmi.2012.7. Epub 2012 Apr 16. Review.

5.

Using the BLT humanized mouse as a stem cell based gene therapy tumor model.

Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA.

J Vis Exp. 2012 Dec 18;(70):e4181. doi: 10.3791/4181.

6.

Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.

Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M, Doi T, Sone A, Suzuki N, Fujiwara H, Yasukawa M, Ishikawa F.

Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13022-7. doi: 10.1073/pnas.1000475107. Epub 2010 Jul 6.

7.

Humanized mice for studying human leukocyte integrins in vivo.

Kim SS, Kumar P, Ye C, Shankar P.

Methods Mol Biol. 2012;757:509-21. doi: 10.1007/978-1-61779-166-6_30.

8.

Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.

Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J, Burzenski L, Gott B, Foreman O, Kavirayani A, Herlihy M, Rossini AA, Shultz LD, Greiner DL.

Clin Immunol. 2010 Apr;135(1):84-98. doi: 10.1016/j.clim.2009.12.008. Epub 2010 Jan 21.

9.

Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy.

Smith DJ, Lin LJ, Moon H, Pham AT, Wang X, Liu S, Ji S, Rezek V, Shimizu S, Ruiz M, Lam J, Janzen DM, Memarzadeh S, Kohn DB, Zack JA, Kitchen SG, An DS, Yang L.

Stem Cells Dev. 2016 Dec 15;25(24):1863-1873. Epub 2016 Oct 18.

10.

Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.

Covassin L, Jangalwe S, Jouvet N, Laning J, Burzenski L, Shultz LD, Brehm MA.

Clin Exp Immunol. 2013 Dec;174(3):372-88. doi: 10.1111/cei.12180.

11.

Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice.

Billerbeck E, Horwitz JA, Labitt RN, Donovan BM, Vega K, Budell WC, Koo GC, Rice CM, Ploss A.

J Immunol. 2013 Aug 15;191(4):1753-64. doi: 10.4049/jimmunol.1201518. Epub 2013 Jul 5.

12.

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model.

Zhen A, Rezek V, Youn C, Rick J, Lam B, Chang N, Zack J, Kamata M, Kitchen S.

J Vis Exp. 2016 Jul 2;(113). doi: 10.3791/54048.

13.

Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.

André MC, Erbacher A, Gille C, Schmauke V, Goecke B, Hohberger A, Mang P, Wilhelm A, Mueller I, Herr W, Lang P, Handgretinger R, Hartwig UF.

J Immunol. 2010 Sep 1;185(5):2710-20. doi: 10.4049/jimmunol.1000583. Epub 2010 Jul 28.

14.

Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.

Chung YS, Son JK, Choi B, Joo SY, Lee YS, Park JB, Moon H, Kim TJ, Kim SH, Hong S, Chang J, Kang MS, Kim SJ.

Clin Immunol. 2015 Apr;157(2):156-65. doi: 10.1016/j.clim.2015.02.005. Epub 2015 Feb 25.

PMID:
25725428
15.

Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models.

Bility MT, Li F, Cheng L, Su L.

J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:120-4. doi: 10.1111/jgh.12092. Review.

16.

Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells.

Joo SY, Chung YS, Choi B, Kim M, Kim JH, Jun TG, Chang J, Sprent J, Surh CD, Joh JW, Kim SJ.

Transplantation. 2012 Dec 15;94(11):1095-102. doi: 10.1097/TP.0b013e318270f392.

PMID:
23222735
17.

NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.

Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T, Greiner DL.

J Immunol. 2000 Mar 1;164(5):2496-507.

18.

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M.

Blood. 2005 Sep 1;106(5):1565-73. Epub 2005 May 26.

19.

Transplantation of human spleen into immunodeficient NOD/SCID IL2Rγ(null) mice generates humanized mice that improve functional B cell development.

Chung YS, Son JK, Choi B, Park JB, Chang J, Kim SJ.

Clin Immunol. 2015 Dec;161(2):308-15. doi: 10.1016/j.clim.2015.09.001. Epub 2015 Sep 7.

PMID:
26360254
20.

Current advances in humanized mouse models.

Ito R, Takahashi T, Katano I, Ito M.

Cell Mol Immunol. 2012 May;9(3):208-14. doi: 10.1038/cmi.2012.2. Epub 2012 Feb 13. Review.

Supplemental Content

Support Center